367 related articles for article (PubMed ID: 9792715)
1. The cytoplasmic loops between domains II and III and domains III and IV in the skeletal muscle dihydropyridine receptor bind to a contiguous site in the skeletal muscle ryanodine receptor.
Leong P; MacLennan DH
J Biol Chem; 1998 Nov; 273(45):29958-64. PubMed ID: 9792715
[TBL] [Abstract][Full Text] [Related]
2. A 37-amino acid sequence in the skeletal muscle ryanodine receptor interacts with the cytoplasmic loop between domains II and III in the skeletal muscle dihydropyridine receptor.
Leong P; MacLennan DH
J Biol Chem; 1998 Apr; 273(14):7791-4. PubMed ID: 9525869
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence resonance energy transfer (FRET) indicates that association with the type I ryanodine receptor (RyR1) causes reorientation of multiple cytoplasmic domains of the dihydropyridine receptor (DHPR) α(1S) subunit.
Polster A; Ohrtman JD; Beam KG; Papadopoulos S
J Biol Chem; 2012 Nov; 287(49):41560-8. PubMed ID: 23071115
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the dihydropyridine receptor Ca2+ channel beta-subunit and ryanodine receptor type 1 strengthens excitation-contraction coupling.
Cheng W; Altafaj X; Ronjat M; Coronado R
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19225-30. PubMed ID: 16357209
[TBL] [Abstract][Full Text] [Related]
5. The recombinant dihydropyridine receptor II-III loop and partly structured 'C' region peptides modify cardiac ryanodine receptor activity.
Dulhunty AF; Karunasekara Y; Curtis SM; Harvey PJ; Board PG; Casarotto MG
Biochem J; 2005 Feb; 385(Pt 3):803-13. PubMed ID: 15511220
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of dihydropyridine receptor II-III loop peptide regulates skeletal muscle calcium release channel function. Evidence for an essential role of the beta-OH group of Ser687.
Lu X; Xu L; Meissner G
J Biol Chem; 1995 Aug; 270(31):18459-64. PubMed ID: 7629172
[TBL] [Abstract][Full Text] [Related]
7. Activation of the skeletal muscle calcium release channel by a cytoplasmic loop of the dihydropyridine receptor.
Lu X; Xu L; Meissner G
J Biol Chem; 1994 Mar; 269(9):6511-6. PubMed ID: 8120002
[TBL] [Abstract][Full Text] [Related]
8. FKBP12 modulation of the binding of the skeletal ryanodine receptor onto the II-III loop of the dihydropyridine receptor.
O'Reilly FM; Robert M; Jona I; Szegedi C; Albrieux M; Geib S; De Waard M; Villaz M; Ronjat M
Biophys J; 2002 Jan; 82(1 Pt 1):145-55. PubMed ID: 11751303
[TBL] [Abstract][Full Text] [Related]
9. Structural requirements of the dihydropyridine receptor alpha1S II-III loop for skeletal-type excitation-contraction coupling.
Kugler G; Weiss RG; Flucher BE; Grabner M
J Biol Chem; 2004 Feb; 279(6):4721-8. PubMed ID: 14627713
[TBL] [Abstract][Full Text] [Related]
10. Activation and inhibition of skeletal RyR channels by a part of the skeletal DHPR II-III loop: effects of DHPR Ser687 and FKBP12.
Dulhunty AF; Laver DR; Gallant EM; Casarotto MG; Pace SM; Curtis S
Biophys J; 1999 Jul; 77(1):189-203. PubMed ID: 10388749
[TBL] [Abstract][Full Text] [Related]
11. Triadin binding to the C-terminal luminal loop of the ryanodine receptor is important for skeletal muscle excitation contraction coupling.
Goonasekera SA; Beard NA; Groom L; Kimura T; Lyfenko AD; Rosenfeld A; Marty I; Dulhunty AF; Dirksen RT
J Gen Physiol; 2007 Oct; 130(4):365-78. PubMed ID: 17846166
[TBL] [Abstract][Full Text] [Related]
12. Bridging the myoplasmic gap: recent developments in skeletal muscle excitation-contraction coupling.
Bannister RA
J Muscle Res Cell Motil; 2007; 28(4-5):275-83. PubMed ID: 17899404
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional characterization of interactions between the dihydropyridine receptor II-III loop and the ryanodine receptor.
Casarotto MG; Cui Y; Karunasekara Y; Harvey PJ; Norris N; Board PG; Dulhunty AF
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1114-7. PubMed ID: 17042924
[TBL] [Abstract][Full Text] [Related]
14. Activating the ryanodine receptor with dihydropyridine receptor II-III loop segments: size and charge do matter.
Casarotto MG; Green D; Pace S; Young J; Dulhunty AF
Front Biosci; 2004 Sep; 9():2860-72. PubMed ID: 15353321
[TBL] [Abstract][Full Text] [Related]
15. Ryanodine modification of RyR1 retrogradely affects L-type Ca(2+) channel gating in skeletal muscle.
Bannister RA; Beam KG
J Muscle Res Cell Motil; 2009; 30(5-6):217-23. PubMed ID: 19802526
[TBL] [Abstract][Full Text] [Related]
16. Caloric restriction prevents age-related decline in skeletal muscle dihydropyridine receptor and ryanodine receptor expression.
Renganathan M; Delbono O
FEBS Lett; 1998 Sep; 434(3):346-50. PubMed ID: 9742952
[TBL] [Abstract][Full Text] [Related]
17. Ca2+-dependent excitation-contraction coupling triggered by the heterologous cardiac/brain DHPR beta2a-subunit in skeletal myotubes.
Sheridan DC; Carbonneau L; Ahern CA; Nataraj P; Coronado R
Biophys J; 2003 Dec; 85(6):3739-57. PubMed ID: 14645065
[TBL] [Abstract][Full Text] [Related]
18. The β(1a) subunit of the skeletal DHPR binds to skeletal RyR1 and activates the channel via its 35-residue C-terminal tail.
Rebbeck RT; Karunasekara Y; Gallant EM; Board PG; Beard NA; Casarotto MG; Dulhunty AF
Biophys J; 2011 Feb; 100(4):922-30. PubMed ID: 21320436
[TBL] [Abstract][Full Text] [Related]
19. An α-helical C-terminal tail segment of the skeletal L-type Ca2+ channel β1a subunit activates ryanodine receptor type 1 via a hydrophobic surface.
Karunasekara Y; Rebbeck RT; Weaver LM; Board PG; Dulhunty AF; Casarotto MG
FASEB J; 2012 Dec; 26(12):5049-59. PubMed ID: 22962299
[TBL] [Abstract][Full Text] [Related]
20. Binding sites of monoclonal antibodies and dihydropyridine receptor alpha 1 subunit cytoplasmic II-III loop on skeletal muscle triadin fusion peptides.
Fan H; Brandt NR; Peng M; Schwartz A; Caswell AH
Biochemistry; 1995 Nov; 34(45):14893-901. PubMed ID: 7578101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
